beta-amyrin has been researched along with Fatty Liver, Nonalcoholic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Alves, APNN; Carvalho, AA; Chaves, MH; Fonseca, SGC; Lima, RP; Nunes, PIG; Oliveira, FTB; Rao, VS; Santos, FA; Silva, RAC; Viana, AFSC; Viana, DA | 1 |
1 other study(ies) available for beta-amyrin and Fatty Liver, Nonalcoholic
Article | Year |
---|---|
α,β-Amyrin prevents steatosis and insulin resistance in a high-fat diet-induced mouse model of NAFLD via the AMPK-mTORC1-SREBP1 signaling mechanism.
Topics: AMP-Activated Protein Kinases; Animals; Diet, High-Fat; Insulin Resistance; Liver; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oleanolic Acid; Sterol Regulatory Element Binding Protein 1 | 2021 |